如果我爱你

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

A |     

曼联名宿基恩近期在接受《天空体育》采访时，谈到了对夏窗大概率离队的利物浦后卫阿诺德的看法。

基恩指出，多年来比阿诺德更优秀的球员也曾选择离开利物浦，比如苏亚雷斯，而俱乐部依然能够继续前行。    (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。阿诺德的能力毋庸置疑，尤其是在进攻三区的表现。但基恩并不认为他的潜在离队会带来任何令人担忧的影响。

他在采访中表示：“这很有趣，我们谈论特伦特（阿诺德）这样一位出色的球员，但如果他离开，就好像世界末日来临一样。如果他真的走了，你只能祝福他一切顺利。他已经为利物浦做出了卓越贡献，是一名非常优秀的球员。但我相信利物浦能够挺过去。”

他还表示“你必须接受这一点，球迷们也要明白，你支持的是俱乐部。当然，你会热爱某些球员，会有自己的偶像，比如肯尼-达格利什、伊恩-拉什这些人。但当他们离开时，球队依然会继续前进，总会有新的优秀球员涌现——这就是足球的本质。

B | 所以，无论特伦特有多出色，利物浦都会没事的。

Current article:http://www.chenzhuaigecoupuhongyuntuizei.sbs/qfzgi0/20260826/125656.htm

Published on:09:14:32